FAVOR III China
Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial
FAVOR III Europe/Japan
Comparison of Quantitative Flow Ratio (QFR) and Conventional Pressure-wire Based Functional Evaluation for Guiding Coronary Intervention. A Randomized Clinical Non-inferiority Trial.
FAVOR IV-QVAS
Quantitative Flow Ratio (QFR) Guided Revascularization Strategy for Patients Undergoing Primary Valve Surgery With Comorbid Coronary Artery Disease.
Address
Headquarters: 14 F, Building 82, No. 1198, North Qinzhou Road, Shanghai, China.
Contact us
Tel: +86 21 5467 0228
Fax: +86 21 5467 0226
sales@